NCT02916719View on ClinicalTrials.gov

Monitoring of Breast Cancers Treated by Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 21, 2016

Primary Completion Date

March 3, 2022

Study Completion Date

March 3, 2022

Conditions
Breast Cancer
Interventions
DEVICE

MRI

MRI examination after the neo-adjuvant radiotherapy, but before the surgical treatment

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER

NCT02916719 - Monitoring of Breast Cancers Treated by Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter